H2020 grant

PHC-14-2015 „Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters” Project acronym: TAT-CF  The project will develop an innovative therapeutic approach for the treatment of Cystic Fibrosis (CF). This condition originates from the defective function of the CFTR protein, a chloride and bicarbonate permeable transmembrane channel. This project will evaluate small molecules capable …

fp7

XENOISLET

FP7 grant “XENOISLET” Project full title: “Macroencapsulated Porcine Pancreatic Islets to cure Diabetes Mellitus type 1/2” “HEALTH.2013.0-1 HEALTH.2013.0-1 programme, Boosting the translation of health research projects’ results into innovative applications for health; Boosting the translation of health research projects’ results into innovative applications for health.” Duration: 2013-2015 Objective: The main objective of the project is to undertake specific final steps …

uszt_en

FP7 contract support grant

Project title: “Sertés pankreáz sejtek xenotranszplantátumának alkalmazása és diagnosztikai fejlesztése cukorbetegség kezelésére” Project code: EU_KP_12-1-2013-0004 Project support: 1 999 367 Ft Project duration: 2013.02.08-2013.06.30 The aim of the present grant application is to support the organization, administrative work and travel costs to our FP7 grant “XENOISLET” (Project full title: “Macroencapsulated Porcine Pancreatic Islets to cure Diabetes Mellitus type 1/2”). With …

uszt_en

Metabolic profiling

Project title: “Modern metabolizmus és szöveti eloszlás vizsgálati módszerek beállítása, alkalmazása gyógyszerhatóanyagok preklinikai kutatás-fejlesztésében” Project code: GOP-1.1.1-11-2012-0454 Project duration: 2013. 01. 01 – 2014. 06. 30 Consortium partner: University of Szeged The aim of the present grant application is to establish and develop novel technologies and methods that are capable of investigating drug metabolism for drug discovery purposes. With the current application …

cytoprotection

Label free technologies

Project code: GOP-1.3.1-11/B-2011-0002 Project title: Establishment of phenotype-based screening technologies for the research and development of drug candidates Project duration: 2011.04.01-2013.03.31 Granting agency: National Development Agency, Hungary Results: AVIDIN developed and optimized several screening technologies based on different label-free methods in order to increase its capacity for in-house development programmes as well as by acting as a CRO for early drug …

Eger In vivo imaging

Inflammation services

Project code: GOP-1.3.1-10B-2010-0016 Project title: Development of a preclinical service package suitable for testing anti-inflammatory compounds Project duration: 2011.01.01-2012.06.30 Granting agency: National Development Agency, Hungary Results: AVIDIN developed and optimized several inflammation models in order to increase its capacity as a CRO for anti-inflammation projects. 1. Mouse in vivo inflammation model Several inflammation models were successfully adopted and optimized in mice: …

Glinolid

Project code: NKFP_07-A2-2008-0220 Project duration: 2008.01.01-2010.12.31 The GLINOLID anti-cancer drug discovery programme is partly supported by the  “National Technology Program” grant from the National Office for Research and Technology (NKTH) of the Hungarian Government. The main focus of the consortium is to develop drug molecules that are not toxic and that could be administered directly to brain and could selectively …

Avinomid

Project code: TECH_08-A1-2008-0306 Project duration: 2008.09.01-2010.12.31 The AVINOMID anti-cancer drug discovery programme is partly supported by the „Ányos Jedlik” grant from the National Office for Research and Technology (NKTH) of the Hungarian Government. This project is based on the observation that new thalidomide analogues, developed by the coordinator, Avidin Ltd., interfere with the lipid metabolism of tumor cells by binding to intracellular …

Hepatocellular carcinoma IBDV

Project title: “Application of superinfection therapy for the adjuvant treatement of hepatocellular carcinoma (HCC), and for decreasing the risk of HCC in hepatitis C positive patients with liver chirosis.” Project code GOP-1.1.1-11-2012-0015 Project duration: 2012.07.02-2014.09.30 Consortium partners: University of Szeged, Corporate Values Ltd.   Avidin as a consortium member took part in two scientific tasks. During the project Avidin developed …